These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11914576)

  • 1. HIV vaccine development in the nonhuman primate model of AIDS.
    Smith SM
    J Biomed Sci; 2002; 9(2):100-11. PubMed ID: 11914576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines.
    Staprans SI; Feinberg MB
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S5-32. PubMed ID: 15285703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monkey Models and HIV Vaccine Research.
    Chen Z
    Adv Exp Med Biol; 2018; 1075():97-124. PubMed ID: 30030791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics.
    Parker RA; Regan MM; Reimann KA
    J Virol; 2001 Nov; 75(22):11234-8. PubMed ID: 11602764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination for HIV-1 and SIV.
    Barouch DH; Letvin NL
    Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an AIDS vaccine using Sendai virus vectors.
    Ishii H; Matano T
    Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and challenges in therapies for AIDS in nonhuman primate models.
    Haigwood NL
    J Med Primatol; 1999; 28(4-5):154-63. PubMed ID: 10593480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1995 May; 24(3):150-68. PubMed ID: 8751055
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonhuman primate models for AIDS.
    Fultz PN
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S230-5. PubMed ID: 8399921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced CD8+ central memory T cells in protection from simian AIDS.
    Vaccari M; Trindade CJ; Venzon D; Zanetti M; Franchini G
    J Immunol; 2005 Sep; 175(6):3502-7. PubMed ID: 16148092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
    Van Rompay KK
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
    Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
    J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.